HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Baicalin Attenuates High Fat Diet-Induced Obesity and Liver Dysfunction: Dose-Response and Potential Role of CaMKKβ/AMPK/ACC Pathway.

AbstractBACKGROUND/AIMS:
Obesity-associated fatty liver disease affects millions of individuals. This study aimed to evaluate the therapeutic effects of baicalin to treat obesity and fatty liver in high fat diet-induced obese mice, and to study the potential molecular mechanisms.
METHODS:
High fat diet-induced obese animals were treated with different doses of baicalin (100, 200 and 400 mg/kg/d). Whole body, fat pad and liver were weighed. Hyperlipidemia, liver steatosis, liver function, and hepatic Ca(2+)/CaM-dependent protein kinase kinase β (CaMKKβ) / AMP-activated protein kinase (AMPK) / acetyl-CoA carboxylase (ACC) were further evaluated.
RESULTS:
Baicalin significantly decreased liver, epididymal fat and body weights in high fat diet-fed mice, which were associated with decreased serum levels of triglycerides, total cholesterol, LDL, alanine transaminase and aspartate transaminase, but increased serum HDL level. Pathological analysis revealed baicalin dose-dependently decreased the degree of hepatic steatosis, with predominantly diminished macrovesicular steatosis at lower dose but both macrovesicular and microvesicular steatoses at higher dose of baicalin. Baicalin dose-dependently inhibited hepatic CaMKKβ/AMPK/ACC pathway.
CONCLUSION:
These data suggest that baicalin up to 400 mg/kg/d is safe and able to decrease the degree of obesity and fatty liver diseases. Hepatic CaMKKβ/AMPK/ACC pathway may mediate the therapeutic effects of baicalin in high fat diet animal model.
AuthorsYouli Xi, Miaozong Wu, Hongxia Li, Siqi Dong, Erfei Luo, Mingbo Gu, Xiao Shen, Yabo Jiang, Yaqun Liu, Hua Liu
JournalCellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology (Cell Physiol Biochem) Vol. 35 Issue 6 Pg. 2349-59 ( 2015) ISSN: 1421-9778 [Electronic] Germany
PMID25896320 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2015 S. Karger AG, Basel.
Chemical References
  • Flavonoids
  • Triglycerides
  • baicalin
  • Aspartate Aminotransferases
  • Alanine Transaminase
  • Calcium-Calmodulin-Dependent Protein Kinase Kinase
  • AMP-Activated Protein Kinases
  • Acetyl-CoA Carboxylase
Topics
  • AMP-Activated Protein Kinases (metabolism)
  • Acetyl-CoA Carboxylase (metabolism)
  • Adipose Tissue (drug effects, metabolism)
  • Alanine Transaminase (blood)
  • Animals
  • Aspartate Aminotransferases (blood)
  • Body Weight (drug effects)
  • Calcium-Calmodulin-Dependent Protein Kinase Kinase (metabolism)
  • Diet, High-Fat (adverse effects)
  • Fatty Liver (blood, drug therapy, metabolism)
  • Flavonoids (pharmacology)
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Obese
  • Obesity (blood, drug therapy, metabolism)
  • Signal Transduction (drug effects)
  • Triglycerides (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: